Ironwood Pharmaceuticals to Participate in the Piper Sandler 34th Annual Healthcare Conference

Rhea-AI Summary

Ironwood Pharmaceuticals (Nasdaq: IRWD) will participate in a fireside chat at the Piper Sandler 34th Annual Healthcare Conference on November 29, 2022, at 4:30 p.m. ET in New York. The event will be accessible via a live webcast on Ironwood's website, where a replay will also be available for 14 days post-conference. Located in Boston, Massachusetts, Ironwood specializes in gastrointestinal healthcare, notably for conditions like IBS-C and CIC, led by its flagship product LINZESS.

BOSTON--(BUSINESS WIRE)-- Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) will participate in a fireside chat at the Piper Sandler 34^th Annual Healthcare Conference on Tuesday, November 29, 2022 at 4:30 p.m. ET at the Lotte New York Palace.

A live webcast of Ironwood’s fireside chat will be accessible through the Investors section of the company’s website at www.ironwoodpharma.com. To access the webcast, please log on to the Ironwood website approximately 15 minutes prior to the start time to ensure adequate time for any software downloads that may be required. A replay of the webcast will be available on Ironwood’s website for 14 days following the conference.

About Ironwood Pharmaceuticals
Ironwood Pharmaceuticals (Nasdaq: IRWD), an S&P SmallCap 600® company, is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients. We are pioneers in the development of LINZESS® (linaclotide), the U.S. branded prescription market leader for adults with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC). Under the guidance of our seasoned industry leaders, we continue to build upon our history of GI innovation and challenge what has been done before to shape what the future holds. We keep patients at the heart of our R&D and commercialization efforts to reduce the burden of GI diseases and address significant unmet needs.

Founded in 1998, Ironwood Pharmaceuticals is headquartered in Boston, Massachusetts.

We routinely post information that may be important to investors on our website at www.ironwoodpharma.com. In addition, follow us on Twitter and on LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221122005006/en/

Investors:

Greg Martini, 617-374-5230

gmartini@ironwoodpharma.com

Matt Roache, 617-621-8395

mroache@ironwoodpharma.com

Source: Ironwood Pharmaceuticals, Inc.

FAQ

What is Ironwood Pharmaceuticals' stock symbol?

Ironwood Pharmaceuticals is listed under the stock symbol 'IRWD'.

When is Ironwood Pharmaceuticals' fireside chat scheduled?

The fireside chat is scheduled for November 29, 2022, at 4:30 p.m. ET.

Where will Ironwood Pharmaceuticals' fireside chat take place?

The fireside chat will take place at the Piper Sandler 34th Annual Healthcare Conference in New York.

How can I access the live webcast of Ironwood Pharmaceuticals' event?

The live webcast can be accessed through the Investors section of Ironwood's website.

How long will the replay of Ironwood Pharmaceuticals' webcast be available?

The replay of the webcast will be available for 14 days following the conference.

What is the main focus of Ironwood Pharmaceuticals?

Ironwood Pharmaceuticals focuses on advancing the treatment of gastrointestinal diseases.